Scaling the collection of socioeconomic and quality of life data among haematopoietic cell transplant patients in the United Kingdom Gemma Pugh 1 , Dawn Hart 1 , Christina Yiallouridou 1 , Karen Dean 1 , Lauren Young 1 , Tomos Llyod-Roberts 1 , Rachel Miller 1 , Robert Danby 1 1 Anthony Nolan, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :Symposium 10 Aims Social and demographic factors can influence patient outcomes following haematopoietic cell transplant (HCT)
Fiber powders or packets offer a practical way to support steady fiber intake without significantly increasing meal size or fullness, which can be particularly helpful during dose escalation or periods of appetite suppression
A trove of clinical trial data on how genetics influence various responses to GLP-1 receptor agonists, including weight loss, likely exists, though that data has been difficult to come by
These patients may display subtle metabolic abnormalities insulin resistance, dyslipidemia, or visceral adiposity despite appearing lean. Clinical markers such as waist circumference, hepatic imaging findings, and elevated liver enzymes (ALT/AST) should prompt further evaluation even when BMI is below 25 kg/m
